Mutations in TJP2 cause progressive cholestatic liver disease

Melissa Sambrotta*, Sandra Strautnieks, Efterpi Papouli, Peter Rushton, Barnaby E. Clark, David A. Parry, Clare V. Logan, Lucy J. Newbury, Binita M. Kamath, Simon Ling, Tassos Grammatikopoulos, Bart E. Wagner, John C. Magee, Ronald J. Sokol, Giorgina Mieli-Vergani, Joshua D. Smith, Colin A. Johnson, Patricia McClean, Michael A. Simpson, A. S. KniselyLaura N. Bull, Richard J. Thompson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Elucidating genetic causes of cholestasis has proved to be important in understanding the physiology and pathophysiology of the liver. Here we show that protein-truncating mutations in the tight junction protein 2 gene (TJP2) cause failure of protein localization and disruption of tight-junction structure, leading to severe cholestatic liver disease. These findings contrast with those in the embryonic-lethal knockout mouse, highlighting differences in redundancy in junctional complexes between organs and species.

Original languageEnglish
Pages (from-to)326-328
Number of pages3
JournalNature Genetics
Volume46
Issue number4
DOIs
Publication statusPublished - Apr 2014

Fingerprint

Dive into the research topics of 'Mutations in TJP2 cause progressive cholestatic liver disease'. Together they form a unique fingerprint.

Cite this